Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone

PURPOSE: Transarterial chemoembolization is accepted therapy for hepatocellular carcinoma (HCC). No randomized trial has demonstrated superiority of chemoembolization compared with embolization, and the role of chemotherapy remains unclear. This randomized trial compares the outcome of embolization...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Clin Oncol
Huvudupphovsmän: Brown, Karen T., Do, Richard K., Gonen, Mithat, Covey, Anne M., Getrajdman, George I., Sofocleous, Constantinos T., Jarnagin, William R., D’Angelica, Michael I., Allen, Peter J., Erinjeri, Joseph P., Brody, Lynn A., O’Neill, Gerald P., Johnson, Kristian N., Garcia, Alessandra R., Beattie, Christopher, Zhao, Binsheng, Solomon, Stephen B., Schwartz, Lawrence H., DeMatteo, Ronald, Abou-Alfa, Ghassan K.
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society of Clinical Oncology 2016
Ämnen:
ORIGINAL REPORTS
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4966514/
https://ncbi.nlm.nih.gov/pubmed/26834067
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2015.64.0821
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk